Skip to main content
Caplight Logo









Zitra Medicines

Zitra Medicines

Private
MelbourneHealthcare & Life Scienceshttps://www.zitramedicines.com/

Last Round

Grant

Jul 1, 2025

Total Funding Raised

$320,000

Company Overview

Zitra Medicines is a biotechnology company that develops mRNA-based therapeutics for severe brain diseases, including monogenic disorders, neurodegenerative conditions, and acute brain injury.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

mRNA therapeuticsblood-brain barrierdrug deliveryneurological disordersbiotech startupdrug discoverymRNA engineeringneurodegenerative diseasebrain deliveryTrojan horse deliverybiotech licensingprecision medicineCNS therapeuticsdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zitra Medicines Comparables

Compare Zitra Medicines with similar companies based on industry and business-model similarity.

Zitra Medicines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ophidion Inc.
81%
Aerska
80%
Gate2Brain
76%

Zitra Medicines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2025

Zitra Medicines Investors

Notable investors and investment history

Zitra Medicines investors
InvestorRounds
mRNA VictoriaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    $320K grant received from mRNA Victoria.

Zitra Medicines Filings

Explore SEC and related filing metadata, where available.

Zitra Medicines filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zitra Medicines's valuation, stock price, and market status.

Is Zitra Medicines a public or private company?

Zitra Medicines is a private company.

What is the current stock price of Zitra Medicines?

Zitra Medicines is a private company with no public stock price. Caplight tracks Zitra Medicines's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Zitra Medicines worth (valuation)?

Valuation information for Zitra Medicines is not publicly available.

Can I buy Zitra Medicines stock?

Zitra Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zitra Medicines's last funding round?

Zitra Medicines's most recent funding round was Grant on July 1, 2025.

Who are the main investors in Zitra Medicines?

Key investors in Zitra Medicines include mRNA Victoria.

Will Zitra Medicines IPO soon?

No public IPO plans have been announced for Zitra Medicines.

How can I track Zitra Medicines secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zitra Medicines's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMelbourne
Employee Range2
Year Founded2024
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?